Tekla Capital Management’s Medpace MEDP Stock Holding History

Tekla Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$6.46M	Buy	26,918 +17,483	+185%	+$3.63M	0.25%	75
2023 Q1	$1.77M	Hold	9,435	–	–	0.07%	125
2022 Q4	$2M	Hold	9,435	–	–	0.08%	112
2022 Q3	$1.48M	Hold	9,435	–	–	0.06%	120
2022 Q2	$1.41M	Hold	9,435	–	–	0.06%	124
2022 Q1	$1.54M	Sell	9,435 -9,436	-50%	-$1.56M	0.05%	131
2021 Q4	$4.11M	Hold	18,871	–	–	0.13%	108
2021 Q3	$3.57M	Hold	18,871	–	–	0.12%	119
2021 Q2	$3.33M	Hold	18,871	–	–	0.11%	136
2021 Q1	$3.1M	Hold	18,871	–	–	0.11%	147
2020 Q4	$2.63M	Hold	18,871	–	–	0.09%	149
2020 Q3	$2.11M	Hold	18,871	–	–	0.08%	154
2020 Q2	$1.75M	Hold	18,871	–	–	0.07%	171
2020 Q1	$1.39M	Hold	18,871	–	–	0.06%	155
2019 Q4	$1.59M	Buy	+18,871	New	+$1.46M	0.06%	158

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tekla Capital Management's MEDP Position: Q2 2023 in Review

Tekla Capital Management increased its Medpace (MEDP) stake by 185% in Q2 2023, buying an estimated $3.63M and bringing the position to 26,918 shares worth $6.46M. The position accounts for 0.25% of the portfolio, ranked #75.

Tekla Capital Management first reported a position in MEDP in Q4 2019 and has held it in 15 quarters since. 464 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

Tekla Capital Management held 26,918 shares of Medpace worth $6.46M as of Q2 2023.
Tekla Capital Management bought 17,483 Medpace shares in Q2 2023, an estimated $3.63M.
Medpace made up 0.25% of Tekla Capital Management's portfolio in Q2 2023, its #75 holding.
Tekla Capital Management first reported a position in Medpace in Q4 2019 and has held it in 15 quarters since.
464 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.